Blackrock Neurotech

Salt Lake City, United States Founded: 2008 • Age: 18 yrs Acquired By Tether
Medical devices for neurological therapies are developed.

About Blackrock Neurotech

Blackrock Neurotech is a Healthcare company based in Salt Lake City (United States) founded in 2008 by Florian Solzbacher and Marcus Gerhardt, and was acquired by Tether in April 2024. Medical devices for neurological therapies are developed. It operates in the Healthcare and Technology sectors. Blackrock Neurotech has raised $22.37 million across 16 funding rounds from investors including HHS, European Union and Tether. Blackrock Neurotech has completed 1 acquisition, including HAHA69. Its chief executive, as recorded, is Marcus Gerhardt. Its website blackrockneurotech.com draws about 35 thousand monthly visits. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its legal entity is BLACKROCK MICROSYSTEMS LLC. Its competitors include Cepheid, Beckman Coulter and Bruker; 1 of its 3 listed competitors has raised funding.

Company details

Blackrock Neurotech developer of medical devices for neurological therapies through life sciences, neurology, developing medical devices, therapeutic devices, neurorehabilitation, and clinic based. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Total Equity Funding
    $22.37M (USD)

    in 16 rounds

  • Latest Funding Round
    $12.37M (USD), Series B

    Apr 2024

  • Investors
    HHS

    & 6 more

  • Investments & Acquisitions
  • Acquired by
    Tether

    (Apr 2024)

Apps and channels of Blackrock Neurotech

its YouTube channel Blackrock Neurotech has 1.51K subscribers and 25 videos.

Blackrock Neurotech
YouTube 1.51K subscribers 25 videos Science & Technology
Open channel

Videos from Blackrock Neurotech

The most watched videos on Blackrock Neurotech's YouTube channel, Blackrock Neurotech (1.51K subscribers). Click a video to play it here.

Neuralace™ | The next-generation of BCI and whole-brain data capture
12.4K views
Nathan Copeland shakes Barack Obama's hand with Blackrock Neurotech's BCI: The NeuroPort Array
10.9K views
A mind controlled masterpiece: James Johnson creates art in Photoshop with BCI
10.6K views
How Does Muscle Sensing Prosthetic and Exoskeleton Technology Work?
5.8K views

More on Blackrock Neurotech.

Funding Insights of Blackrock Neurotech

Blackrock Neurotech has successfully raised a total of $22.37M across 16 strategic funding rounds. The most recent funding activity was a Series B round of $12.37 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $22.37M
  • Total Rounds 16
  • Last Round Series B — $12.37M
  • First Round $1.06M

    (Sep 2009)

  • Investors Count 6

Latest 10 of 16 funding rounds of Blackrock Neurotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2024$12.37MSeries B––
–
Sep 2023$1.49MGrant––
Aug 2023$496,413Grant––
May 2021$10MSeries A–re.Mind Capital
Mar 2021$1.29MGrant––
Jun 2020$1.7MGrant––
Aug 2019$1.72MGrant––
Sep 2016$774,483Grant––
Jun 2015$709,154Grant––
Sep 2014$222,049Grant––
Valuation history

7 investors in total: 5 institutional and 2 angel.

Investors in Blackrock Neurotech

Blackrock Neurotech has secured backing from 7 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include HHS, European Union and Tether.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Early-stage investments are provided in mental health and brain health sectors.
remind.vcLondon, United Kingdom
Public health and human services are overseen by HHS.
1953hhs.gov
Administers health care and support for military personnel and operations.
health.milFalls Church, United States
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
USD-backed stablecoins are issued on multiple blockchains by Tether.
2014tether.toSanta Monica, United States

Peter Thiel

Co-founder of PayPal, early Facebook investor, influential tech angel investor
unknown_08073300646446a2b

Tim Sievers

Angel investor and entrepreneur, co-founder of Razorpay, focused on fintech
unknown_57744436336243848
Premium access

Investor details for Blackrock Neurotech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Blackrock Neurotech

52 people are tracked at Blackrock Neurotech (15 in leadership, 3 in board & advisors, 34 in team).

NameRoleGroup
Florian Solzbacher
Co-Founder & CSOLeadership
Marcus Gerhardt
Co-Founder & CEOLeadership
Julia Brown
Head Of Data Strategy & AILeadership
Kristen McIntosh
VP, Business OperationsLeadership
David Burk
Director, PMOLeadership
Rob Franklin
VP, BCILeadership
Sherman Wiebe
Director of European OfficeLeadership
Danny Powell
Vp, BCI Strategy & Business DevelopmentLeadership
Bryan Satterfield
Director, OperationsLeadership
Raj Bhandari
VP, Development ElectrodeLeadership
Shehan Jaro
VP, FinanceLeadership
Bryan Howell
DirectorLeadership
David Hoagland
Chief Operating Officer L Senior Vice PresidentLeadership
Thomas Thiele
Chief Financial OfficerLeadership
Sandeep Negi
Director of Research ElectrodesLeadership
Christian Angermayer
Co-ChairmanBoard & advisors
Tim Sievers
Co-ChairmanBoard & advisors
Pierre-Emmanuel Gaillardon
AdvisorBoard & advisors
Balaji Srikanthan
Senior Research And Development EngineerTeam
Erman Turan
InvestorTeam

32 more people are available in the full profile.

Premium access

Complete people profiles for Blackrock Neurotech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Blackrock Neurotech

Blackrock Neurotech has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include HAHA69.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
HAHA69 is recognized for providing online slot gaming services.
mind-x.ioBethesda, United States2016Apr 2022••••
Premium access

Complete acquisition details for Blackrock Neurotech

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Blackrock Neurotech

5 dated milestones of Blackrock Neurotech across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded Blackrock Neurotech is founded.
  2. Funding First funding round of $1.1M.
  3. Acquisition Acquires HAHA69.
  4. Funding Latest funding round, Series B, of $12.4M.
  5. Exit Acquired by Tether.

Competitors of Blackrock Neurotech

Blackrock Neurotech has 3 listed competitors in our database, 1 of them funded. They include Cepheid, Beckman Coulter and Bruker.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cepheid.com1996Sunnyvale, United States$19.1M1,299
Developer of molecular diagnostic testing solutions
beckman.com1935Brea, United States
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
bruker.com1960United States9,707
Diversified research instrument systems are manufactured and supplied.
Premium access

Detailed competitors of Blackrock Neurotech

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Blackrock Neurotech

The website of Blackrock Neurotech (blackrockneurotech.com) receives about 35K visits a month.

  • Monthly visits
    35K

    ▼ 1% vs previous month

Similar websites

Websites whose visitors overlap most with Blackrock Neurotech. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
neurotechx.com
neurotechx.com
100%
#1,842,250–
neuronexus.com
85%
7.8K#2,725,284View details
brainmind.org
brainmind.org
53%
#3,020,265–
foresight.org
foresight.org
49%
#861,488–
msesupplies.com
33%
165.4K#248,209View details

Top companies in Neurology

3 companies that operate in the same segment as Blackrock Neurotech (Neurology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
2013San Francisco, California, United StatesUSD 214.78 MUSD 21.05 M211
Developer of therapeutics for psychiatric and neurologic diseases
2002New York, New York, United StatesUSD 80.87 MUSD 250.31 M600
Biologics platform developed for intracellular delivery in rare diseases.
2016Boston, Massachusetts, United StatesUSD 175.25 MUSD 25.42 M183
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Blackrock Neurotech

Premium access

Complete news archive for Blackrock Neurotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Blackrock Neurotech

Blackrock Neurotech was founded in 2008 and raised its 1st funding round 1 year after it was founded.

Blackrock Neurotech is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.

Marcus Gerhardt is the CEO of Blackrock Neurotech, as recorded in our data. They have also founded this company.

Blackrock Neurotech is a funded company, having raised a total of $22.37M across 16 funding rounds to date. The company's 1st funding round was a Grant of $222.05K, raised on Sep 2009.

Blackrock Neurotech developer of medical devices for neurological therapies through life sciences, neurology, developing medical devices, therapeutic devices, neurorehabilitation, and clinic based. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Blackrock Neurotech's top competitors include Cepheid, Bruker and Beckman Coulter.

Blackrock Neurotech has made 1 acquisition, including HAHA69.

Blackrock Neurotech has 7 investors. Key investors include HHS, European Union, Tether, re.Mind Capital, and Peter Thiel.

Blackrock Neurotech operates through Blackrock Microsystems Llc.

Yes. Blackrock Neurotech was acquired by Tether in April 2024.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available